Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk

Carcinogenesis

Volumn 25, Issue 8, 2004, Pages 1395-1401

  Ito, Hidemi ^a,b   Matsuo, Keitaro ^a   Hamajima, Nobuyuki ^c   Mitsudomi, Tetsuya ^a   Sugiura, Takahiko ^a   Saito, Toshiko ^a   Yasue, Tetsuo ^a   Lee, Kyoung Mu ^d   Kang, Daehee ^d   Yoo, Keun Young ^d   Sato, Shigeki ^b   Ueda, Ryuzo ^b   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEOPROTEIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; UNCLASSIFIED DRUG; X RAY CROSS COMPLEMENTING GROUP PROTEIN; APEX1 PROTEIN, HUMAN; ARGININE; ASPARTIC ACID; DNA BINDING PROTEIN; GLUTAMIC ACID; GLUTAMINE; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA MODIFICATION; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE FREQUENCY; GENETIC CODE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; JAPAN; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ALLELE; CODON; ENVIRONMENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG TUMOR; MIDDLE AGED; RISK; RISK FACTOR; SMOKING;

ADULT; AGED; ALLELES; ARGININE; ASPARTIC ACID; CODON; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; GLUTAMINE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS; SMOKING;

EID: 4344602545     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh153     Document Type: Article

References (51)

1. Hecht,S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
2. Blot,D. and Fraumeni,J.J. (1996) Cancers of the lung and pleura. In Schottenfeld,D. and Fraumeni,J.F.,Jr (eds) Cancer Epidemiology and Prevention. Oxford University Press, New York, pp. 635-637.
3. Mattson,M.E., Pollack,E.S. and Cullen,J.W. (1987) What are the odds that smoking will kill you? Am. J. Public Health, 77, 425-431.
4. Caporaso,N., Landi,M.T. and Vineis,P. (1991) Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics, 1, 4-19.
5. Goode,E.L., Ulrich,C.M. and Potter,J.D. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1513-1530.
6. Sellers,T.A., Potter,J.D., Bailey-Wilson,J.E., Rich,S.S., Rothschild,H. and Elston,R.C. (1992) Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition. Cancer Res., 52, 2694s-2697s.
7. Raunio,H., Husgafvel-Pursiainen,K., Anttila,S., Hietanen,E., Hirvonen,A. and Pelkonen,O. (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene, 159, 113-121.
8. Perera,F.P. (1996) Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J. Natl Cancer Inst., 88, 496-509.
9. Li,D., Wang,M., Cheng,L., Spitz,M.R., Hittelman,W.N. and Wei,Q. (1996) In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res., 56, 3638-3641.
10. Li,D., Firozi,P.F., Wang,L.E., Bosken,C.H., Spitz,M.R., Hong,W.K. and Wei,Q. (2001) Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res., 61, 1445-1450.
11. Spitz,M.R., Wu,X., Wang,Y., Wang,L.E., Shete,S., Amos,C.I., Guo,Z., Lei,L., Mohrenweiser,H. and Wei,Q. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res., 61, 1354-1357.
12. Wei,Q., Cheng,L., Hong,W.K. and Spitz,MR. (1996) Reduced DNA repair capacity in lung cancer patients. Cancer Res., 56, 4103-4107.
13. Wei,Q. and Spitz,M.R. (1997) The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev., 16, 295-307.
14. Vidal,A.E., Boiteux,S., Hickson,I.D. and Radicella,J.P. (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J., 20, 6530-6539.
15. Lu,A.L., Li,X., Gu,Y., Wright,P.M. and Chang,D.Y. (2001) Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem. Biophys., 35, 141-170.
16. Ramana,C.V., Boldogh,I., Izumi,T. and Mitra,S. (1998) Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc. Natl Acad. Sci. USA, 95, 5061-5066.
17. Bennett,R.A., Wilson,D.M.,3rd, Wong,D. and Demple,B. (1997) Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc. Natl Acad. Sci. USA, 94, 7166-7169.
18. Hadi,M.Z., Coleman,M.A., Fidelis,K., Mohrenweiser,H.W. and Wilson,I.D. (2000) Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res., 28, 3871-3879.
19. Hu,J.J., Smith,T.R., Miller,M.S., Mohrenweiser,H.W., Golden,A. and Case,L.D. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-922.
20. Misra,R.R., Ratnasinghe,D., Tangrea,J.A., Virtamo,J., Andersen,M.R., Barrett,M., Taylor,P.R. and Albanes,D. (2003) Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3 and APE/ref-1 and the risk of lung cancer among male smokers in Finland. Cancer Lett., 191, 171-178.
21. Lunn,R.M., Langlois,R.G., Hsieh,L.L., Thompson,C.L. and Bell,D.A. (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophotin A variant frequency. Cancer Res., 59, 2557-2561.
22. Abdel-Rahman,S.Z. and El-Zein,R.A. (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett., 159, 63-71.
23. Ratnasinghe,D., Yao,S.X., Tangrea,J.A., Qiao,Y.L., Andersen,M.R., Barrett,M.J., Giffen,C.A., Erozan,Y., Tockman,M.S. and Taylor,P.R. (2001) Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 119-123.
24. Divine,K.K., Gilliland,F.D., Crowell,R.E., Stidley,C.A., Bocklage,T.J., Cook,D.L. and Belinsky,S.A. (2001) The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res., 461, 273-278.
25. Butkiewicz,D., Rusin,M., Enewold,L., Shields,P.G., Chorazy,M. and Harris,C.C. (2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22, 593-597.
26. David-Beabes,G.L. and London,S.J. (2001) Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer, 34, 333-339.
27. Park,J.Y., Lee,S.Y., Jeon,H.S., Bae,N.C., Chae,S.C., Joo,S., Kim,C.H., Park,J.H., Kam,S., Kim,I.S. and Jung,T.H. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev., 11, 23-27.
28. Zhou,W., Liu,G., Miller,D.P., Thurston,S.W., Xu,L.L., Wain,J.C., Lynch,T.J., Su,L. and Christiani,D.C. (2003) Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 12, 359-365.
29. Matullo,G., Palli,D., Peluso,M. et al. (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis, 22, 1437-1445.
30. Palli,D., Russo,A., Masala,G., Saieva,C., Guarrera,S., Carturan,S., Munnia,A., Matullo,G. and Peluso,M. (2001) DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer, 94, 121-127.
31. Wang,Y., Spitz,M.R., Zhu,Y., Dong,Q., Shete,S. and Wu,X. (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Rep., 2, 901-908.
32. Matullo,G., Guarrera,S., Carturan,S., Peluso,M., Malaveille,C., Davico,L., Piazza,A. and Vineis,P. (2001) DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer, 92, 562-567.
33. Duell,E.J., Wiencke,J.K., Cheng,T.J., Varkonyi,A., Zuo,Z.F., Ashok,T.D., Mark,E.J., Wain,J.C., Christiani,D.C. and Kelsey,K.T. (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-971.
34. Shen,H., Spitz,M.R., Qiao,Y., Guo,Z., Wang,L.E., Bosken,C.H., Amos,C.I. and Wei,Q. (2003) Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int. J. Cancer, 107, 84-88.
35. Tajima,K., Hirose,K., Inoue,M., Takezaki,T., Hamajima,N. and Kuroishi,T. (2000) A model of practical cancer prevention for out-patients visiting a hospital: the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC). Asian Pac. J. Cancer Prev., 1, 35-47.
36. Hamajima,N., Matsuo,K., Saito,T., Hirose,K., Inoue,M., Takezaki,T., Kuroishi,T. and Tajima,K. (2001) Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac. J. Cancer Prev., 2, 99-107.
37. Hamajima,N., Saito,T., Matsuo,K., Kozaki,K., Takahashi,T. and Tajima,K. (2000) Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn. J. Cancer Res., 91, 865-868.
38. Khoury,M.J. and Flanders,W.D. (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol., 144, 207-213.
39. Chen,S., Tang,D., Xue,K., Xu,L., Ma,G., Hsu,Y. and Cho,S.S. (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis, 23, 1321-1325.
40. Shen,M.R., Jones,I.M. and Mohrenweiser,H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58, 604-608.
41. Xing,D., Qi,J., Miao,X., Lu,W., Tan,W. and Lin,D. (2002) Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int. J. Cancer, 100, 600-605.
42. Matsuo,K., Hamajima,N., Suzuki,R., Andoh,M., Nakamura,S., Seto,M., Morhisima,Y. and Tajima,K. (2004) Lack of association between DNA base excision repair gene XRCC1 Arg399Gln polymorphism and risk of malignant lymphoma. Cancer Genet. Cytogenet., 149, 77-80.
43. Duell,E.J., Holly,E.A., Bracci,P.M., Wiencke,J.K. and Kelsey,K.T. (2002) A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res., 62, 4630-4606.
44. van Gils,C.H., Bostick,R.M., Stern,M.C. and Taylor,J.A. (2002) Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol. Biomarkers Prev., 11, 1279-1284.
45. Duell,E.J., Millikan,R.C., Pittman,G.S., Winkel,S., Lunn,R.M., Tse,C.K., Eaton,A., Mohrenweiser,H.W., Newman,B. and Bell,D.A. (2001) Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomarkers Prev., 10, 217-222.
46. Shen,H., Xu,Y., Qian,Y., Yu,R., Qin,Y., Zhou,L., Wang,X., Spitz,M.R. and Wei,Q. (2000) Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer, 88, 601-606.
47. Ratnasinghe,D.L., Yao,S.X., Forman,M., Qiao,Y.L. Andersen,M.R., Giffen,C.A., Erozan,Y., Tockman,M.S. and Taylor,P.R. (2003) Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk. Anticancer Res., 23, 627-632.
48. Ruano-Ravina,A., Figueiras,A., Montes-Martinez,A. and Barros-Dios,J.M. (2003) Dose-response relationship between tobacco and lung cancer: new findings. Eur. J. Cancer Prev., 12, 257-263.
49. Nakachi,K., Imai,K., Hayashi,S., Watanabe,J. and Kawajiri,K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
50. Vineis,P. (1997) Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer, 71, 1-3.
51. Inoue,M., Tajima,K., Hirose,K., Hamajima,N., Takezaki,T., Kuroishi,T. and Tominaga,S. (1997) Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age and season. J. Clin. Epidemiol., 50, 69-77.